Results 31 to 40 of about 9,553 (133)

COVID-19 and Preeclampsia: Overlapping Features in Pregnancy

open access: yesRambam Maimonides Medical Journal, 2022
Coronavirus disease 2019 (COVID-19) is a global respiratory disease with unique features that have placed all medical professionals in an alarming situation.
Jayanthi Rajendran, Saravanan Sumathi
doaj   +1 more source

Soluble (pro)renin receptor increased by hypoxia maintains oxidative metabolism in trophoblasts [PDF]

open access: yesJournal of Molecular Endocrinology, 2020
Elevated soluble (pro)renin receptor (s(P)RR) concentration in maternal blood is associated with gestational hypertension and preeclampsia. Placenta has abundant expression of (P)RR, and the binding of (P)RR with pyruvate dehydrogenase E1 beta subunit (PDHB) is reported to maintain oxidative metabolism.
Chikahito, Suda   +4 more
openaire   +2 more sources

(Pro)Renin Receptor Decoy Peptide PRO20 Protects against Oxidative Renal Damage Induced by Advanced Oxidation Protein Products

open access: yesMolecules, 2023
Chronic kidney disease (CKD) is associated with advanced oxidation protein products (AOPPs). A recent study has shown that AOPP-induced renal tubular injury is mediated by the (pro)renin receptor (PRR).
Hui Fang   +3 more
doaj   +1 more source

Soluble (Pro)Renin Receptor and Blood Pressure During Pregnancy [PDF]

open access: yesHypertension, 2012
The renin–angiotensin system is believed to influence blood pressure (BP) during pregnancy, but the associations between BP during pregnancy and the soluble form of the (pro)renin receptor (s[P]RR), a new component of the tissue renin–angiotensin system, remain undetermined.
Noriyoshi, Watanabe   +11 more
openaire   +2 more sources

A Novel Single-Strand RNAi Therapeutic Agent Targeting the (Pro)renin Receptor Suppresses Ocular Inflammation

open access: yesMolecular Therapy: Nucleic Acids, 2017
The receptor-associated prorenin system (RAPS) refers to the pathogenic mechanism whereby prorenin binding to the (pro)renin receptor [(P)RR] dually activates the tissue renin-angiotensin system (RAS) and RAS-independent intracellular signaling.
Atsuhiro Kanda   +7 more
doaj   +1 more source

Water Deprivation Increases (Pro)renin Receptor Levels in the Kidney and Decreases Plasma Concentrations of Soluble (Pro)renin Receptor

open access: yesThe Tohoku Journal of Experimental Medicine, 2016
Water deprivation activates the renin-angiotensin system. We have hypothesized that the renal expression of (pro)renin receptor ((P)RR), a specific receptor for renin and prorenin, could be changed under dehydration. Moreover, plasma levels of soluble (P)RR (s(P)RR) comprising of the extracellular domain of (P)RR may reflect the renal (P)RR expression.
Tamura, Yuma   +9 more
openaire   +3 more sources

The (pro)renin receptor: a novel biomarker and potential therapeutic target for various cancers

open access: yesCell Communication and Signaling, 2020
Background The (pro) renin receptor ((P)RR) plays important roles in various pathways, such as the Wnt/β-catenin, renin-angiotensin system (RAS), MAPK/ERK and PI3K/AKT/mTOR pathways, that are involved in a wide range of physiological and pathological ...
Juan Wang   +4 more
doaj   +1 more source

(Pro)renin receptor: Involvement in diabetic retinopathy and development of molecular targeted therapy

open access: yesJournal of Diabetes Investigation, 2019
The renin–angiotensin system (RAS), a crucial regulator of systemic blood pressure (circulatory RAS), plays distinct roles in pathological angiogenesis and inflammation in various organs (tissue RAS), such as diabetic microvascular complications.
Atsuhiro Kanda, Susumu Ishida
doaj   +1 more source

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy